Compugen completes enrollment in MAIA-ovarian trial of COM701, readout due Q1 2027Nov 9Quarterly updateCOM701Compugen Ltd
AstraZeneca registers Phase III bladder cancer trial; joins Natera-led breast cancer studyJul 23Weekly roundup, 5 itemsAstraZenecaAZD6489